Defective MSCs from CML patients maintained leukemia cells immature phenotype (left), whereas allogeneic MSCs restored normal MPL expression patterns, followed by the activation of the downstream signaling pathway of MPL (right). Here, MPL is linked to chronic myelogenous leukemia, BCR-ABL1 positive.